Literature DB >> 1683874

Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme.

H F Upchurch1, E Conway, M K Patterson, M D Maxwell.   

Abstract

Extending our previous observation that tissue transglutaminase (TGase) binds to extracellular matrix (ECM) fibronectin, we report here that endogenous tissue TGase is localized on the adjacent ECM after puncture wounding embryonic human lung fibroblasts (WI-38). The bound TGase persisted at the wound site for many hours, demonstrated by immunofluorescence and by catalytic activity using an overlay assay. The binding characteristics of TGase with ECM were studied further by the addition of exogenous TGase to cell monolayers and monitoring by immunofluorescence or overlay catalytic activity assays. Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5'-triphosphate (GTP), guanosine 5'-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold. The Ca(++)-dependent change was a concentration-dependent effect on soluble exogenous TGase, rather than an effect on ECM. Immunofluorescent techniques showed that binding of exogenous TGase to ECM was prevented by prior mixing with fibronectin or collagen, but not with several other ECM components, including laminin, elastin, chondroitin sulfate, heparan sulfate, and hyaluronic acid. ECM-bound TGase was released by 2 M potassium thiocyanate (KSCN) treatment but was not released by treatment with a variety of amino acids, salts, reducing agents, glycerol, or other chaotropic agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683874     DOI: 10.1002/jcp.1041490304

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  43 in total

1.  Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression.

Authors:  G Brusco; P Muzi; R Ciccocioppo; F Biagi; M G Cifone; G R Corazza
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.

Authors:  K E Achyuthan; T C Rowland; P J Birckbichler; K N Lee; P D Bishop; A M Achyuthan
Journal:  Mol Cell Biochem       Date:  1996-09-06       Impact factor: 3.396

Review 3.  Cultured epithelial autografts: diving from surgery into matrix biology.

Authors:  M Raghunath; M Meuli
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

4.  Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase.

Authors:  M Raghunath; B Höpfner; D Aeschlimann; U Lüthi; M Meuli; S Altermatt; R Gobet; L Bruckner-Tuderman; B Steinmann
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

Review 5.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

6.  Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis.

Authors:  G D'Argenio; V Cosenza; G Riegler; N Della Valle; F Deritis; G Mazzacca
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

7.  The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

Authors:  T S Johnson; M Griffin; G L Thomas; J Skill; A Cox; B Yang; B Nicholas; P J Birckbichler; C Muchaneta-Kubara; A Meguid El Nahas
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

8.  Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.

Authors:  Angelo Agathanggelou; Ivan Bièche; Jalal Ahmed-Choudhury; Barbara Nicke; Reinhard Dammann; Shairaz Baksh; Boning Gao; John D Minna; Julian Downward; Eamonn R Maher; Farida Latif
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

9.  Transglutaminase in azoxymethane-induced colon cancer in the rat.

Authors:  G D'Argenio; P Iovino; V Cosenza; I Sorrentini; F De Ritis; M Delle Cave; F P D'Armiento; G Mazzacca
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

10.  Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.

Authors:  B Friedrichs; H Riedmiller; H W Goebel; U Rausch; G Aumüller
Journal:  Urol Res       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.